학술논문
Randomized Comparison of Intermediate-Dose Cytarabine Plus Mitoxantrone (IMA) Versus Standard-Dose Cytarabine Plus Daunorubicin (DA) for Induction Therapy in AML Patients >60 Years. Results from the SAL 60+ Trial
Document Type
Abstract
Author
Röllig, Christoph ; Kramer, Michael ; Gabrecht, Maria ; Hänel, Mathias ; Herbst, Regina ; Kaiser, Ulrich ; Schmitz, Norbert; Kullmer, Johannes ; Fetscher, Sebastian ; Link, Hartmut ; Mantovani-Löffler, Luisa ; Krümpelmann, Ulrich ; Neuhaus, Thomas ; Heits, Frank ; Einsele, Hermann; Ritter, Barbara ; Bornhäuser, Martin ; Schetelig, Johannes; Thiede, Christian; Mohr, Brigitte ; Schaich, Markus; Platzbecker, Uwe; Schäfer-Eckart, Kerstin ; Krämer, Alwin ; Berdel, Wolfgang E; Serve, Hubert ; Ehninger, Gerhard; Schuler, Ulrich S.
Source
In Blood 3 December 2015 126(23):222-222
Subject
Language
ISSN
0006-4971